FDA clears NovaBone's Putty delivery system
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for NovaBone Products' Putty MIS delivery system, for use during minimally-invasive orthopaedic procedures. It is designed to precisely deliver bone putty to the surgical site, including the extremities, pelvis or posterolateral spine. The device comprises a syringe preloaded with the firm's Putty bone graft substitute and 6mm-diameter cannulae of varying lengths. Jacksonville, Florida-based NovaBone plans to launch a "number of new products this year and through 2011".